|
Characteristic
|
Before surgery
|
After 3 months
|
After 6 months
|
|---|
|
(n = 13)
|
(n = 13)
|
(n = 13)
|
|---|
|
BMI (kg/m2)
|
42.2 ± 4.2
|
35.9 ± 4.7*
|
33.0 ± 2.9###
|
|
Body weight (kg)
|
113.4 ± 14.7
|
94.2 ± 13.9*
|
90.1 ± 12.4##
|
|
Waist circumference (cm)
|
123.2 ± 12.0
|
107.8 ± 7.7
|
107.2 ± 13.7#
|
|
Fat mass (kg)
|
52.8 ± 9.3
|
37.8 ± 9.1*
|
34.4 ± 7.1###
|
|
Lean mass (kg)
|
61.0 ± 5.9
|
56.4 ± 5.2
|
55.7 ± 6.1
|
|
Fasting glucose (mg/dL)
|
97.5 ± 25.1
|
87.0 ± 19.2
|
82.5 ± 11.6
|
|
A1C (%)
|
5.4 ± 0.7
|
5.2 ± 0.5
|
5.1 ± 0.4
|
|
Cholesterol (mg/dL)
|
165 ± 20.5
|
155.8 ± 27.1
|
160.9 ± 24.1
|
|
HDL cholesterol (mg/dL)
|
39.0 ± 9.5
|
39.1 ± 10.6
|
42.0 ± 10.2
|
|
LDL cholesterol (mg/dL)
|
105.7 ± 20.3
|
105.3 ± 20.1
|
100.4 ± 16.5
|
|
Triglycerides (mg/dL)
|
121.5 ± 67.0
|
86.5 ± 36.2
|
91.9 ± 40.1
|
|
Insulin (mU/L)
|
17.1 ± 7.7
|
9.0 ± 5.0
|
7.5 ± 4.4#
|
|
HOMA-IR
|
2.0 ± 1.0
|
1.1 ± 0.6*
|
0.9 ± 0.5#
|
|
Systolic BP (mmHg)
|
136 ± 9.6
|
113 ± 5.4***
|
114 ± 7.5###
|
|
Diastolic BP (mmHg)
|
102 ± 6.8
|
76 ± 5.4***
|
78.5 ± 6.4###
|
|
% of weight loss
|
NA
|
− 17%
|
− 20.50%
|
|
% blood glucose reduction
|
NA
|
− 12.90%
|
− 17.50%
|
|
% Cholesterol reduction
|
NA
|
− 5.50%
|
− 2.50%
|
|
% Triglycerides reduction
|
NA
|
− 30.90%
|
− 26.60%
|
|
% LDL reduction
|
NA
|
− 0.40%
|
− 5.00%
|
|
% HDL change
|
NA
|
− 0.25%
|
7.40%
|
- Values are given as mean ± SD. One-way ANOVA, post-test Tukey
- BMI body mass index, A1C hemoglobin A1C, HDL high-density lipoprotein, LDL low-density lipoprotein, HOMA-IR homeostatic model assessment-insulin resistance; NA not applicable
- *,#,$p < 0.05; **,##,$$p < 0.01; ***,###,$$$p < 0.001
- * Baseline vs. 3 months
- # Baseline vs. 6 months
- $ 6 months vs. 3 months
